v3.26.1
Segment (Tables)
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Reporting Segment Financial Information The table below
details the Company’s segment net loss, significant expenses, and other segment items (in thousands). The measure of segment assets is reported on the condensed consolidated balance sheets as total assets.
Three Months Ended March 31,
20262025
Revenue$2 $7 
Less:
Technical operations12,394 17,895 
Clinical development12,643 8,674 
Support functions5,638 8,455 
Lease costs3,709 4,446 
Operations management2,727 4,984 
Research activities2,410 3,530 
Other segment items(1)
(15,366)4,218 
Net loss$24,153 $52,195 
1.Includes stock-based compensation, depreciation, other operating income, net, interest income, net, and other income, net. For the three months ended March 31, 2026, includes a $17.6 million gain associated with the settlement of the SPA put/call.